Superficial fibromatoses are genetically distinct from deep fibromatoses

Modern Pathology

Volumn 14, Issue 7, 2001, Pages 695-701

  Montgomery, E ^a   Lee, J H ^a   Abraham, S C ^a   Wu, T T ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

catenin gene; APC gene; Desmoid tumor; Dupuytren's contracture; Fibromatosis; Gardner's syndrome

Indexed keywords

APC PROTEIN; BETA CATENIN; DNA; GLYCOGEN SYNTHASE KINASE 3BETA;

ADULT; AGED; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DESMOID TUMOR; DNA SEQUENCE; DUPUYTREN CONTRACTURE; EXON; FEMALE; FIBROMATOSIS; FINGER; FOOT SOLE; GARDNER SYNDROME; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PEYRONIE DISEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SCHOOL CHILD; SUPERFICIAL CANCER;

ADULT; AGED; BETA CATENIN; CELL NUCLEUS; CYTOSKELETAL PROTEINS; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; FIBROMA; GENES, APC; HUMANS; MALE; MIDDLE AGED; MUTATION; TRANS-ACTIVATORS;

EID: 0034912650     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880374     Document Type: Article

References (64)

1. The fibromatoses: A clinicopathologic classification based on 140 cases
2. Infantile digital fibromatosis. Identification of actin filaments in cytoplasmic inclusions by heavy meromyosin binding
3. The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population
4. The desmoid tumor. II. Analysis of factors possibly contributing to the etiology and growth behavior
5. A genetic and clinical study of intestinal polyposis, a predisposing factor for carcinoma of the colon and rectum
6. Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis
7. Follow-up study of a family group exhibiting dominant inheritance for a syndrome including intestinal polyps, osteomas, fibromas, and epidermal cysts
8. Familial adenomatous polyposis: Desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444
9. Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene
10. Hereditary desmoid disease due to a frame-shift mutation at codon 1924 of the APC gene
11. The relationship between frequencies of extracolonic manifestations and the position of APC germline mutation in patients with familial adenomatous polyposis
12. Hereditary desmoid disease in a family with a germline Alu I repeat mutation of the APC gene
13. Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3′ APC gene mutation
14. Somatic mutation of APC gene in desmoid tumour in familial adenomatous polyposis
15. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors)
16. Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumours
17. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis
18. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor)
19. Cytogenetic, clinical, and morphologic correlations in 78 cases of fibromatosis: A report from the CHAMP Study Group. Chromosomes and morphology
20. Multiple clonal chromosome abnormalities in Peyronie's disease
21. Frequent beta-catenin mutations in juvenile nasopharyngeal angiofibromas
22. Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections
23. Sporadic fundic gland polyps: Common gastric polyps arising through activating mutations in the beta-catenin gene
24. Fundic gland polyps in familial adenomatous polyposis: Neoplasms with frequent somatic adenomatous polyposis coli gene alterations
25. Beta-catenin and adenomatous polyposis coli (APC) mutations in adenomas from hereditary non-polyposis colorectal cancer patients
26. Intracellular distribution of beta-catenin in colorectal adenomas, carcinomas and Peutz-Jeghers polyps
27. Beta-catenin expression in primary and metastatic colorectal carcinoma
28. Beta-catenin mutations in cell lines established from human colorectal cancers
29. Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations
30. Down-regulation of beta-catenin by the colorectal tumor suppressor APC requires association with Axin and beta-catenin
31. Nuclear translocation of beta-catenin in colorectal cancer
32. Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer
33. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC
34. A beta-catenin mutation in a sporadic colorectal tumor of the RER phenotype and absence of beta-catenin germline mutations in FAP patients
35. Activation of the beta-catenin gene by interstitial deletions involving exon 3 as an early event in colorectal tumorigenesis
36. Defects in the regulation of beta-catenin in colorectal cancer
37. Beta-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas
38. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer
39. Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor)
40. Beta-catenin in soft tissue sarcomas: Expression is related to proliferative activity in high-grade sarcomas
41. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly
42. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein
43. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta
44. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin
45. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling
46. Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level
47. Structural basis of the Axin-adenomatous polyposis coli interaction
48. A germline mutation at the extreme 3′ end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta- catenin in the desmoid tumor
49. A novel case of a sporadic desmoid tumour with mutation of the beta catenin gene
50. Novel mutations and inactivation of both alleles of the APC gene in desmoid tumors
51. Coexistence of somatic and germ-line mutations of APC gene in desmoid tumors from patients with familial adenomatous polyposis
52. Axin and hepatocellular carcinomas
53. Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas
54. Beta-catenin mutations are frequent in hepatocellular carcinomas but absent in adenomas induced by diethylnitrosamine in B6C3F1 mice
55. Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas
56. Mutations in beta-catenin and APC genes are uncommon in esophageal and esophagogastric junction adenocarcinomas
57. Lessons from hereditary colorectal cancer
58. Sporadic medulloblastomas contain oncogenic beta-catenin mutations
59. Somatic mutations of the APC gene in sporadic hepatoblastomas
60. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene
61. Nasopharyngeal angiofibroma in patients with familial adenomatous polyposis
62. Nasopharyngeal angiofibroma: An APC-gene-associated tumor?
63. Desmoid tumours in familial adenomatous polyposis